Etid klinik pou Depresyon nan Maryland
28 etid pou Depresyon ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 3 a 99 · Tout sèks · Mizajou Sep 28, 2026 · NCT00024635Characterization and Treatment of Adolescent Depression
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 11 a 25 · Tout sèks · Mizajou Sep 28, 2026 · NCT03388606A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Delricht Research - Rockville, Rockville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07621237A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Sunstone Medical, PC, Rockville
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 25, 2026 · NCT06793397Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT03065335RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Sunstone Therapies, PC, Rockville
- Sheppard Pratt, Towson
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 14, 2026 · NCT06511908Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 10, 2026 · NCT03973268Neurobiology of Suicide
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT02543983A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pharmasite Research Inc., Baltimore
Ap rekriteFaz 3
Laj 18 a 74 · Tout sèks · Mizajou Sep 8, 2026 · NCT07076407Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
- Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore
Ap rekriteFaz 1 bonè
Laj 18 a 85 · Tout sèks · Mizajou Sep 4, 2026 · NCT04123314Psilocybin in Chronic Low Back Pain and Depression
- Johns Hopkins University School of Medicine, Baltimore
Ap rekriteFaz 1
Laj 21 a 80 · Tout sèks · Mizajou Sep 4, 2026 · NCT06355414A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Gaithersburg
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 26, 2026 · NCT07300969PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Aug 18, 2026 · NCT04582916[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Aug 17, 2026 · NCT05703685Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Aug 14, 2026 · NCT06462196A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 6, 2026 · NCT07412756E-Mindfulness Approaches for Living After Breast Cancer
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- ak 14 plis
Ap rekriteFaz 3
Laj 18 a 50 · Tout sèks · Mizajou Aug 4, 2026 · NCT06748222Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Gaithersburg
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06966401Strength and Pain-Coping Through Resilience and Knowledge
- Johns Hopkins School of Nursing, Baltimore
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07228520CAPABLE Transplant
- Johns Hopkins School of Nursing, Baltimore
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Jul 20, 2026 · NCT06326905CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
- Walter Reed National Medical Military Center, Bethesda
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05663034A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- Sheppard Pratt Health System, Inc., Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT03887715A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Sheppard Pratt, Baltimore
- Sunstone Medical, PC, Rockville
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou May 11, 2026 · NCT06524830Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
- Johns Hopkins University, Baltimore
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou May 6, 2026 · NCT07227337VR-PMR for Post-Burn Symptoms
- Johns Hopkins Bayview Medical Center, Baltimore
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT07317271Long-term Observation of Participants With Mood Disorders
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Nov 28, 2025 · NCT04877977Glucose Variability and Cognition in Prediabetes
- Baltimore VA Geriatric Research Education and Clinical Center (GRECC), Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Mar 30, 2025 · NCT04201600Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.